{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:06:25Z","timestamp":1773734785975,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T00:00:00Z","timestamp":1477699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["BMBF\/NGFN 01GR0808"],"award-info":[{"award-number":["BMBF\/NGFN 01GR0808"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12035-016-0243-2","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T03:05:02Z","timestamp":1477710302000},"page":"7194-7203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of Plasma \u03b2-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Janine","family":"Gronewold","sequence":"first","affiliation":[]},{"given":"Olga","family":"Todica","sequence":"additional","affiliation":[]},{"given":"Hans-Wolfgang","family":"Klafki","sequence":"additional","affiliation":[]},{"given":"Ulla K.","family":"Seidel","sequence":"additional","affiliation":[]},{"given":"Britta","family":"Kaltwasser","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[]},{"given":"Heike","family":"Bruck","sequence":"additional","affiliation":[]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,10,29]]},"reference":[{"issue":"2\u20133","key":"243_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2007.09.058","volume":"428","author":"L Abdullah","year":"2007","unstructured":"Abdullah L, Paris D, Luis C, Quadros A, Parrish J, Valdes L, Keegan AP, Mathura V et al (2007) The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels. Neurosci Lett 428(2\u20133):53\u201358. doi:\n10.1016\/j.neulet.2007.09.058","journal-title":"Neurosci Lett"},{"issue":"3","key":"243_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00002093-200207000-00009","volume":"16","author":"Z Arvanitakis","year":"2002","unstructured":"Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR (2002) Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord 16(3):187\u2013190","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"243_CR3","volume-title":"Regensburger Wortfl\u00fcssigkeits-Test (RWT)","author":"S Aschenbrenner","year":"2000","unstructured":"Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortfl\u00fcssigkeits-Test (RWT). Hogrefe, G\u00f6ttingen"},{"key":"243_CR4","unstructured":"B\u00e4umler G (1985) Farb-Wort-Interferenztest (FWIT) nach J.R. Stroop. Hogrefe, G\u00f6ttingen"},{"issue":"2","key":"243_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/jad-2009-1144","volume":"18","author":"S Cammarata","year":"2009","unstructured":"Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C, Fornaro M, Vitali A et al (2009) Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment. J Alzheimer\u2019s Dis: JAD 18(2):267\u2013271. doi:\n10.3233\/jad-2009-1144","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"12","key":"243_CR6","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1021\/cn400129p","volume":"4","author":"MJ Chiu","year":"2013","unstructured":"Chiu MJ, Yang SY, Horng HE, Yang CC, Chen TF, Chieh JJ, Chen HH, Chen TC et al (2013) Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer\u2019s disease. ACS Chem Neurosci 4(12):1530\u20131536. doi:\n10.1021\/cn400129p","journal-title":"ACS Chem Neurosci"},{"issue":"12","key":"243_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/archneurol.2010.189","volume":"67","author":"SA Cosentino","year":"2010","unstructured":"Cosentino SA, Stern Y, Sokolov E, Scarmeas N, Manly JJ, Tang MX, Schupf N, Mayeux RP (2010) Plasma ss-amyloid and cognitive decline. Arch Neurol 67(12):1485\u20131490. doi:\n10.1001\/archneurol.2010.189","journal-title":"Arch Neurol"},{"issue":"12","key":"243_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/s1474-4422(06)70611-1","volume":"5","author":"NJ Fullwood","year":"2006","unstructured":"Fullwood NJ, Hayashi Y, Allsop D (2006) Plasma amyloid-beta concentrations in Alzheimer\u2019s disease: an alternative hypothesis. Lancet Neurol 5(12):1000\u20131001. doi:\n10.1016\/s1474-4422(06)70611-1\n\nauthor reply 1002-1003","journal-title":"Lancet Neurol"},{"key":"243_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9218-y","author":"J Gronewold","year":"2015","unstructured":"Gronewold J, Klafki HW, Baldelli E, Kaltwasser B, Seidel UK, Todica O, Volsek M, Haussmann U et al (2015) Factors responsible for plasma beta-amyloid accumulation in chronic kidney disease. Mol Neurobiol. doi:\n10.1007\/s12035-015-9218-y","journal-title":"Mol Neurobiol"},{"issue":"1","key":"243_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/jad-2011-111418","volume":"28","author":"O Hansson","year":"2012","unstructured":"Hansson O, Stomrud E, Vanmechelen E, Ostling S, Gustafson DR, Zetterberg H, Blennow K, Skoog I (2012) Evaluation of plasma Abeta as predictor of Alzheimer\u2019s disease in older individuals without dementia: a population-based study. J Alzheimer\u2019s Dis: JAD 28(1):231\u2013238. doi:\n10.3233\/jad-2011-111418","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"243_CR11","volume-title":"Wechsler Memory Scale\u2014revised edition","author":"C H\u00e4rting","year":"2000","unstructured":"H\u00e4rting C, Markowitsch HJ, Neufeld U, Calabrese P, Deisinger K, Kessler J (2000) Wechsler Memory Scale\u2014revised edition, German edn. Huber, Bern","edition":"German"},{"key":"243_CR12","volume-title":"Hospital Anxiety and Depression Scale - Deutsche Version (HADS-D)","author":"C Herrmann-Lingen","year":"2005","unstructured":"Herrmann-Lingen C, Buss U, Snaith RP (2005) Hospital Anxiety and Depression Scale - Deutsche Version (HADS-D). Hans Huber, Bern"},{"issue":"6","key":"243_CR13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Holtzman DM (2013) Biomarker modeling of Alzheimer\u2019s disease. Neuron 80(6):1347\u20131358. doi:\n10.1016\/j.neuron.2013.12.003","journal-title":"Neuron"},{"issue":"7","key":"243_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/archneurol.2011.1841","volume":"69","author":"A Koyama","year":"2012","unstructured":"Koyama A, Okereke OI, Yang T, Blacker D, Selkoe DJ, Grodstein F (2012) Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol 69(7):824\u2013831. doi:\n10.1001\/archneurol.2011.1841","journal-title":"Arch Neurol"},{"issue":"3","key":"243_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","volume":"268","author":"YM Kuo","year":"2000","unstructured":"Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR et al (2000) Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun 268(3):750\u2013756. doi:\n10.1006\/bbrc.2000.2222","journal-title":"Biochem Biophys Res Commun"},{"key":"243_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8854-y","author":"YH Liu","year":"2014","unstructured":"Liu YH, Xiang Y, Wang YR, Jiao SS, Wang QH, Bu XL, Zhu C, Yao XQ et al (2014) Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance. Mol Neurobiol. doi:\n10.1007\/s12035-014-8854-y","journal-title":"Mol Neurobiol"},{"issue":"1","key":"243_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-014-8694-9","volume":"51","author":"YH Liu","year":"2015","unstructured":"Liu YH, Wang YR, Xiang Y, Zhou HD, Giunta B, Manucat-Tan NB, Tan J, Zhou XF et al (2015) Clearance of amyloid-beta in Alzheimer\u2019s disease: shifting the action site from center to periphery. Mol Neurobiol 51(1):1\u20137. doi:\n10.1007\/s12035-014-8694-9","journal-title":"Mol Neurobiol"},{"issue":"19","key":"243_CR18","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1212\/01.wnl.0000306696.82017.66","volume":"70","author":"OL Lopez","year":"2008","unstructured":"Lopez OL, Kuller LH, Mehta PD, Becker JT, Gach HM, Sweet RA, Chang YF, Tracy R et al (2008) Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology 70(19):1664\u20131671. doi:\n10.1212\/01.wnl.0000306696.82017.66","journal-title":"Neurology"},{"issue":"6012","key":"243_CR19","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science (New York, NY) 330(6012):1774. doi:\n10.1126\/science.1197623","journal-title":"Science (New York, NY)"},{"issue":"7","key":"243_CR20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1212\/wnl.0000000000001263","volume":"84","author":"J Nettiksimmons","year":"2015","unstructured":"Nettiksimmons J, Ayonayon H, Harris T, Phillips C, Rosano C, Satterfield S, Yaffe K (2015) Development and validation of risk index for cognitive decline using blood-derived markers. Neurology 84(7):696\u2013702. doi:\n10.1212\/wnl.0000000000001263","journal-title":"Neurology"},{"issue":"10","key":"243_CR21","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/archneurol.2009.207","volume":"66","author":"OI Okereke","year":"2009","unstructured":"Okereke OI, Xia W, Selkoe DJ, Grodstein F (2009) Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch Neurol 66(10):1247\u20131253. doi:\n10.1001\/archneurol.2009.207","journal-title":"Arch Neurol"},{"key":"243_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(16)00070-3","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, Holtta M, Rosen C et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. doi:\n10.1016\/s1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"issue":"10","key":"243_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1517\/14712598.2014.935332","volume":"14","author":"F Panza","year":"2014","unstructured":"Panza F, Solfrizzi V, Imbimbo BP, Logroscino G (2014) Amyloid-directed monoclonal antibodies for the treatment of Alzheimer\u2019s disease: the point of no return? Expert Opin Biol Ther 14(10):1465\u20131476. doi:\n10.1517\/14712598.2014.935332","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl 19","key":"243_CR24","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.5301\/jn.5000162","volume":"25","author":"A Pilotto","year":"2012","unstructured":"Pilotto A, Panza F, Sancarlo D, Paroni G, Maggi S, Ferrucci L (2012) Usefulness of the multidimensional prognostic index (MPI) in the management of older patients with chronic kidney disease. J Nephrol 25(Suppl 19):S79\u2013S84. doi:\n10.5301\/jn.5000162","journal-title":"J Nephrol"},{"key":"243_CR25","doi-asserted-by":"crossref","unstructured":"Poljak A, Crawford JD, Smythe GA, Brodaty H, Slavin MJ, Kochan NA, Trollor JN, Wen W, et al (2016) The relationship between plasma Abeta levels, cognitive function and brain volumetrics: Sydney Memory and Ageing Study. Curr Alzheimer Res 13(3):243\u2013255.","DOI":"10.2174\/1567205013666151218150202"},{"issue":"10","key":"243_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1176\/appi.ajgp.13.10.914","volume":"13","author":"N Pomara","year":"2005","unstructured":"Pomara N, Willoughby LM, Sidtis JJ, Mehta PD (2005) Selective reductions in plasma Abeta 1-42 in healthy elderly subjects during longitudinal follow-up: a preliminary report. Am J Geriatr Psychiatr: Off J Am Assoc Geriatr Psychiatr 13(10):914\u2013917. doi:\n10.1176\/appi.ajgp.13.10.914","journal-title":"Am J Geriatr Psychiatr: Off J Am Assoc Geriatr Psychiatr"},{"key":"243_CR27","volume-title":"Trail making test","author":"RM Reitan","year":"1992","unstructured":"Reitan RM (1992) Trail making test. Reitan Neuropsychology Laboratory, Tucson, AZ"},{"issue":"1","key":"243_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","volume":"5","author":"AE Roher","year":"2009","unstructured":"Roher AE, Esh CL, Kokjohn TA, Castano EM, Van Vickle GD, Kalback WM, Patton RL, Luehrs DC et al (2009) Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia : J Alzheimer\u2019s Assoc 5(1):18\u201329. doi:\n10.1016\/j.jalz.2008.10.004","journal-title":"Alzheimer\u2019s & Dementia : J Alzheimer\u2019s Assoc"},{"key":"243_CR29","unstructured":"Russ M (2002) Rey complex figure test. Anleitung f\u00fcr die Anwendung im Frankfurter Neuropsychologischen Testprofil (FNTP). \nhttp:\/\/www.fntp.de\/mediapool\/80\/807841\/data\/CFT_Scoring.pdf\n\n. Accessed 5 Sept 2012"},{"issue":"1","key":"243_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000334742","volume":"35","author":"S Salem","year":"2012","unstructured":"Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M et al (2012) Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35(1):31\u201339. doi:\n10.1159\/000334742","journal-title":"Am J Nephrol"},{"issue":"3","key":"243_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2013.366","volume":"85","author":"UK Seidel","year":"2014","unstructured":"Seidel UK, Gronewold J, Volsek M, Todica O, Kribben A, Bruck H, Hermann DM (2014) The prevalence, severity, and association with HbA1c and fibrinogen of cognitive impairment in chronic kidney disease. Kidney Int 85(3):693\u2013702. doi:\n10.1038\/ki.2013.366","journal-title":"Kidney Int"},{"issue":"10","key":"243_CR32","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/jnnp.2010.205757","volume":"81","author":"TT Seppala","year":"2010","unstructured":"Seppala TT, Herukka SK, Hanninen T, Tervo S, Hallikainen M, Soininen H, Pirttila T (2010) Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. J Neurol Neurosurg Psychiatry 81(10):1123\u20131127. doi:\n10.1136\/jnnp.2010.205757","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"243_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/jad-2011-101977","volume":"26","author":"F Song","year":"2011","unstructured":"Song F, Poljak A, Valenzuela M, Mayeux R, Smythe GA, Sachdev PS (2011) Meta-analysis of plasma amyloid-beta levels in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 26(2):365\u2013375. doi:\n10.3233\/jad-2011-101977","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"2","key":"243_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2008.02.019","volume":"435","author":"M Takata","year":"2008","unstructured":"Takata M, Nakashima M, Takehara T, Baba H, Machida K, Akitake Y, Ono K, Hosokawa M et al (2008) Detection of amyloid beta protein in the urine of Alzheimer\u2019s disease patients and healthy individuals. Neurosci Lett 435(2):126\u2013130. doi:\n10.1016\/j.neulet.2008.02.019","journal-title":"Neurosci Lett"},{"issue":"8","key":"243_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11(8):457\u2013470. doi:\n10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"243_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2010.1995","volume":"305","author":"K Yaffe","year":"2011","unstructured":"Yaffe K, Weston A, Graff-Radford NR, Satterfield S, Simonsick EM, Younkin SG, Younkin LH, Kuller L et al (2011) Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 305(3):261\u2013266. doi:\n10.1001\/jama.2010.1995","journal-title":"JAMA"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0243-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T01:36:59Z","timestamp":1506735419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0243-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,29]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0243-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,29]]}}}